Skip to content
Established 1991 Linden, New Jersey · 908-975-0250
Lark Research High Quality Independent Investment Research

Risk/Reward archive

Sectors

March 29, 2017PEG · Utilities

PSEG Dances to Stay Fit

Public Service Enterprise Group (PSEG) is a public utility holding company whose principal direct operating subsidiaries include Public Service Electric & Gas (PSE&G), which serves 2.2 million electric customers and 1.8 million gas customers along a northeast to…

Continue reading →
March 23, 2017ARCH · Materials

An Update on Arch Coal (ARCH)

Arch Coal emerged from bankruptcy on October 5, 2016 and recently filed its 2016 10-K which included its fourth quarter performance (Oct. 2 to Dec. 31) as a reorganized (i.e. successor) company. With its quick emergence from Chapter…

Continue reading →
December 10, 2016CWCO · Utilities

Update on Consolidated Water (CWCO)

Shares of Consolidated Water (CWCO) have struggled over the past several months, extending a period of underperformance vs. peers that stretches back for more than a year. Year-to-date (through 12/9), CWCO has posted a loss (including dividends) of…

Continue reading →
November 20, 2016ARCH · Materials

Arch Coal Post-Bankruptcy

On October 5, Arch Coal officially exited the bankruptcy process.  The exit came just short of nine months after it had filed for bankruptcy on January 11, 2016.  This was a remarkable achievement, given the company’s size, the…

Continue reading →
July 19, 2016ARCH · Energy

Coal Sector Update

The Dow Jones U.S. Coal Mining Sector Index has more than doubled so far this year, up 117.6% through July 15, obviously much better than the broader DJ US Total Market Index’s gain of 5.7%. Much of coal’s gains…

Continue reading →
May 24, 2016Materials · Utilities

The Coal Industry Goes Bust

Very few industries have suffered a decline as steep as coal’s. In just five years, the coal industry has gone from relatively healthy to almost entirely bankrupt. Major coal producers – including Peabody Energy, Arch Coal, and Alpha…

Continue reading →
April 22, 2016Health Care · MRK

An Update on Merck (MRK)

Product Pipeline Successes. Merck has enjoyed a couple of notable successes in its product pipeline over the past year. The first and most important is Keytruda (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) immunotherapy treatment for cancer. Keytruda…

Continue reading →